oprah and semaglutide Winfrey Gains Weight After Quitting Ozempic In the Spotlight: Oprah's Weight

Targets Semaglutide is a longchain peptide (large MW, highly hydrophilic) requiring parenteral delivery or specialized oral formulations to protect against enzymatic and GI degradation

This confirms that BSO inhibits parasite -glutamyl cysteine synthetase in P

Blocking the catalytic breakdown of GLP-1 and GIP, allows for postprandial insulin release [44]

However, many insurance companies do not cover weight loss medications such as Wegovy and Zepbound when used solely for weight reduction

Its possible that those who have access to GLP-1 prescriptions have the financial means to also access other things that would impact OUD or AUD